雅虎香港 搜尋

登入

搜尋結果

  1. 178.00
    加入追蹤清單
    -1.54 (-0.86%)
    收市價:下午 4:00 EDT2024年5月22日, 週三
    178.73 +0.73 (+0.41%)
    市前:上午 9:10 EDT2024年5月23日, 週四
    (USD)。延遲價格。
    全螢幕顯示
    • 前收市價
      179.54
      開市
      178.41
      買盤
      177.95 x 200
      賣出價
      178.09 x 100
    • 今日波幅
      176.78 - 178.85
      52週波幅
      115.83 - 179.95
      成交量
      16.11M
      平均成交量
      22.64M
    • 市值
      2188.79B
      Beta值 (5年，每月)
      1.02
      市盈率 (最近12個月)
      27.34
      每股盈利 (最近12個月)
      6.51
    • 業績公佈日
      2024-07-23
      遠期股息及收益率
      0.80 & 0.45%
      除息日
      2024-06-10
      1年預測目標價
      184.50

    查看更多GOOG

    相關股票

    查看全部

  2. www.carsgen.com › en › newsNews | CARsgen

    2023年11月20日 · Newsroom. CARsgen Announces Formation of its Clinical Advisory Board. Nov 20, 2023. SHANGHAI, China, November 20, 2023, CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the formation of its Clinical Advisory ...

  3. www.carsgen.com › en › about-usLeadership | CARsgen

    Leadership. Was appointed as a Director in February 2018, and the CEO and the Chief Scientific Officer in February 2021. He was re-designated as an executive Director in February 2021. Dr. Li has also held positions at CARsgen Therapeutics. He has been a director and the chief executive officer since October 2014, and the chief scientific ...

  4. www.carsgen.com › en › about-usClinical Advisory Board | CARsgen

    Landgren is a board-certified hematologist-oncologist and he has published more than 500 papers and chapter books with a primary focus on multiple myeloma, MGUS (monoclonal gammopathy of undetermined significance), and smoldering myeloma. Dr. Landgren’s research focuses the mechanisms underlying progression from precursor disease to frank ...